Pricing Availability   Qty
Description: Selective GPR55 agonist; neurobehaviorally inactive
Alternative Names: Abnormal-cannabidiol
Chemical Name: 4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol
Purity: ≥97% (HPLC)
Citations (3)
Literature (1)

Biological Activity for Abn-CBD

Abn-CBD is a neurobehaviorally inactive cannabinoid that acts as a selective agonist for GPR55 (EC50 values are 2.5, >30 and >30 μM at GPR55, CB1 and CB2 receptors respectively). Increases phosphorylation of protein kinases in, and migration of, human umbilical vein endothelial cells.

Technical Data for Abn-CBD

M. Wt 314.47
Formula C21H30O2
Storage Desiccate at -20°C
Purity ≥97% (HPLC)
CAS Number 22972-55-0
PubChem ID 89949
Smiles C=[C@](C)[C@@H]1CCC(C)=C[C@H]1[C@]2=C(O)C=C(O)C=C2CCCCC

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for Abn-CBD

Solubility Soluble in methyl acetate (supplied pre-dissolved - 5mg/ml)

Product Datasheets for Abn-CBD

Certificate of Analysis / Product Datasheet
Select another batch:

References for Abn-CBD

References are publications that support the biological activity of the product.

Ho and Hiley (2003) Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br.J.Pharmacol. 138 1320 PMID: 12711633

Jarai et al (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc.Natl.Acad.Sci.U.S.A. 96 14136 PMID: 10570211

Mo et al (2004) Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Eur.J.Pharmacol. 489 21 PMID: 15063151

Ryberg et al (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br.J.Pharmacol. 152 1092 PMID: 17876302

If you know of a relevant reference for Abn-CBD, please let us know.

View Related Products by Target

View Related Products by Product Action

View all GPR55 Agonists

Keywords: Abn-CBD, Abn-CBD supplier, Selective, GPR55, agonists, neurobehaviorally, inactive, cannabinoids, receptors, cannabidiol, Abnormal-cannabidiol, 1297, Tocris Bioscience

3 Citations for Abn-CBD

Citations are publications that use Tocris products. Selected citations for Abn-CBD include:

Hao et al (2015) Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis. Cell Death Dis 21 38 PMID: 25569804

Yang et al (2014) Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radic Biol Med 68 260 PMID: 24398069

Esposito et al (2007) Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. Br J Pharmacol 151 1272 PMID: 17592514

Do you know of a great paper that uses Abn-CBD from Tocris? Please let us know.

Reviews for Abn-CBD

There are currently no reviews for this product. Be the first to review Abn-CBD and earn rewards!

Have you used Abn-CBD?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Cannabinoid Receptor Ligands Scientific Review

Cannabinoid Receptor Ligands Scientific Review

Written by Roger Pertwee, this review discusses compounds which affect the activity of the endocannabinoid system, focusing particularly on ligands that are most widely used as experimental tools and denotes compounds available from Tocris.